Abstract
BackgroundMammographic density adversely affects diagnostic accuracy and may be a risk factor for breast cancer. Mammographic density is affected by hormone replacement therapy (HRT).
ObjectiveTo assess mammographic density in postmenopausal women with and without HRT.
MethodPart I. Mammographic density was determined in 1232 postmenopausal women attending a breast screening clinic. Density was compared between HRT users and nonusers in three age groups. When available, previous mammograms were assessed for interval density change. Part II. Density change in 162 women during transition from premenopause to postmenopause was recorded. HRT effect was assessed.
ResultsPart I. There was no density difference between postmenopausal HRT-users and nonusers younger than age 55. Thereafter, the density was significantly less in nonusers. In the majority of HRT-users the density remained at pretreatment levels but density increased in 8% of women after HRT was started. Part II. Of 117 HRT nonusers followed over menopause 38% had a density decrease before age 55. Of those started on HRT, 80% had no density change, 18% decreased density and 2% increased density.
ConclusionsThe density decreases significantly after age 55 with the greatest change occurring between age 55 and 64. This decrease does not occur in the majority of HRT-users. Usually HRT maintains the density present at the time HRT is started. Density decreases after HRT is started in some women suggesting refractoriness to hormones. In fewer than 8% of women density increases commensurate with HRT. Any adverse effect of HRT may depend on the receptivity of the epithelial elements which, in turn, may be reflected by the mammographic density at the time HRT is started.
Similar content being viewed by others
References
Fisher ER, Palekar A, Kim WS, Redmond C: Histopathology of mammographic patterns. Am J Clin Pathol 69: 421–426, 1978
Wellings SR, Wolfe JN: Correlative studies of the histologic and radiographic appearance of the breast parenchyma. Radiology 129: 299–306, 1978
Page DL, Winfield AC: The dense mammogram. AJR 147: 487–489, 1986
Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NS, Kopans DB, Meyer JE: Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. Cancer 61: 266–271, 1988
Krook PM: Mammographic parenchymal patterns as risk indicators for incident cancer in a screening program: an extended analysis. AJR 131: 1031–1035, 1978
Andersson I, Janzon L, Pettersson H: Radiographic patterns of mammary parenchyma; variations with age at examination and age at first birth. Radiology 138: 59–62, 1981
Grove JS, Goodman MJ, Gilbert FI, Mi MP: Factors associated with mammographic pattern. Br J Radiol 58: 21–25, 1985
Whitehouse GH, Leinster SJ: The variation of breast parenchymal patterns with age. Br J Radiol 58: 315–318, 1985
Whitehead J, Carlile T, Kopecky KJ, Thompson DJ, Gilbert FI, Present AJ, Threatt Krook P, Hadaway E: Mammographic parenchymal patterns. A study of the masking hypothesis of Egan and Mosteller. Cancer 56: 1280–1286, 1985
Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev 9: 146–174, 1987
Hart BL, Steinbock RT, Mettler FA, Pathak DR, Bartlow SA: Age and race related changes in mammographic parenchymal patterns. Cancer 63: 2537–2539, 1989
Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F: Diet, mammographic features of breast tissue and breast cancer risk. Am J Epidemiol 130: 14–24, 1989
van Gils CH, Otten JDM, Verbeek AL, Hendriks JH: Short communication: breast parenchymal patterns and their changes with age. Br J Radiol 68: 1133–1135, 1995
Stomper PC, D'souza DJ, DiNitto PA, Arredondo MA: Analysis of parenchymal density on mammograms in 1353 women 25- 79 years old. AJR 167: 1261–1265, 1996
Wolfe JN: The prominent duct pattern as an indicator of cancer risk. Oncology 23: 149–158, 1969
Wilkinson E, Clopton C, Gordonson J, Green R, Hill A, Pike C:Mammographic parenchymal patterns and the risk of breast cancer. J Natl Cancer Inst 59: 1397–1400, 1977
Hainline S, Myers L, McLellland R, Newell J, Grufferman R, Shingleton W: Mammographic pattern and risk of breast cancer. AJR 130: 1157–1158, 1978
Egan RL, McSweeney M: Mammographic parenchymal patterns and risk of breast cancer. Radiology 133: 65–70, 1979
Threatt B: Association between mammographic parenchymal pattern classification and incidence of breast cancer. Cancer 45: 2250–2256, 1980
Gravelle IH, Bulstrode JC, Bullbrook RD, Wang DY, Allen D, Hayward JL: A prospective study of mammographic parenchymal patterns and risk of breast cancer. Br J Radiol 59: 487–491, 1986
Goodwin PJ, Boyd NF: Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. Am J Epidemiol 127: 1097–1108, 1988
Bartow SA, Pathak DR, Merrler FA: Radiographic microcalification and parenchymal pattern as indicators of histologic “high risk” benign breast disease. Cancer 66: 1721–1725, 1990
Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN: Mammographic densities and risk of breast cancer. Cancer 67: 2833–2838, 1991
Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 15: 196–208, 1993
Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG: A nested case control study of mammographic patterns, breast volume, and breast cancer. Cancer Causes Control 6: 431— 438, 1995
Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R: Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87: 1622–1629, 1995
Byng JW, Yaffe MJ, Lockwood GA, Little LE, Tritchler DL, Boyd NE: Automated analysis of mammographic densities and breast carcinoma risk. Cancer 80: 66–74, 1997
Fajardo LL, Hillman BJ, Frey C: Correlation between breast parenchymal patterns and mammographers certainty of diagnosis. Invest Radiol 23: 505–508, 1988
Bird RE, Wallace TW, Yankaskas BC: Analysis of cancer missed at screening mammography. Radiology 184: 613–617, 1992
Ma L, Fishell E, Wright B, HannaW, Allan S, Boyd NF: Casecontrol study of factors associated with failure to detect cancer by mammography. J Natl Cancer Inst 84: 781–785, 1992
Kerlikowske K, Grady D, Barclay J, Sickels E, Ernster V: Do age, breast density, and family history affect the sensitivity of first screening mammography? JAMA 276: 33–38, 1996
Persson I, Yuen J, Bergkvist L, Schairer C: Cancer incidence and mortality in women receiving estrogen and estrogen- progestin replacement therapy - long-term follow-up of a Swedish cohort. Internat J Cancer 67: 327–332, 1996
Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW: Hormonal replacement therapy: mammographic manifestations. Radiol 174: 199–201, 1990
Cohen MEL: Effect of hormone replacement on cancer detection by mammography. (Letter) Lancet 349: 1624, 1997
Erel CT, Seyisoglu H, Senturk ML, Akman C, Ersavasti G, Benian A, Uras C, Altug A, Ertungealp E: Mammographic changes in women on hormonal replacement therapy. Maturitas 25: 51–57, 1996
Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L: Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196: 433–437, 1995
Marugg RC, van der Mooren MJ, Hendriks JH, Rolland R, Ruijs SH: Mammographic changes in postmenopausal women on hormonal replacement therapy. Euro Radiol 7: 749–755, 1997
Rand T, Heytmanek G, Seifert M,Wunderbaldinger P, Kreuzer S, Schneider B, Wolf G: Mammography in women undergoing hormone replacement therapy. Possible effects revealed at routine examination. Acta Radiolog 38: 228–231, 1997
McNicholas MM, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP: Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. AJR 163: 311–315, 1994
Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE: Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 174: 487–490, 1990
Leung W, Goldberg F, Zee B, Sterns E: Mammographic density in women on postmenopausal hormone replacement therapy (HRT). Surgery 122: 669–674, 1997
Harvey JA, Pinkerton JV, Herman CR: Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst 89: 1623–1625, 1997
Peck DP, Lowman RM: Estrogen and the postmenopausal breast: mammographic considerations. JAMA 240: 1733–1735, 1978
Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 86: 431–436, 1994
Bergkvist L, Adami HO, Persson I, Bergstrom R, Krusemo UB: Prognosis after breast cancer diagnoses in women exposed to estrogen and estrogen- progestogen replacement therapy. Am J Epidemiol 130: 221–228, 1989
Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 332: 1589–1593, 1995
Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047–1059, 1997
Ewertz M: Hormone therapy in the menopause and breast cancer risk - a review. Maturitas 23: 241–246, 1996
Hunt K, Vessey M, McPherson K: Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 97: 1080–1086, 1990
Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL: A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265: 1985–1990, 1991
Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE: Postmenopausal hormone replacement and mortality. New Engl J Med 336: 1769–1775, 1997
LaCroix AZ, Burke W: Breast cancer and hormone replacement. Lancet 350: 1042–1043, 1997
Sterns EE: Age related breast diagnosis. Can J Surg 35: 41–45, 1992
Dupont WD, Page DL: Menopausal estrogen replacement therapy and a breast cancer. Arch Int Med 151: 67–72, 1991
Henrich J: The postmenopausal estrogen/breast cancer controversy. JAMA 268: 1900–1902, 1992
Helzlsouer KJ, Couzi R: Hormones and breast cancer. Cancer 76: 2059–2063, 1995
Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron J, Clapp RW, Bogdan G, Willett WC: Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 142: 788–795, 1995
Sellers TA, Mink PJ, Cerhan JR, Zheng W, Anderson KE, Kushi LH, Folsom AR: The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Annals Internal Med 127: 973–980, 1997
Beral V, Banks E, Reeves G, Wallis M: Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet 349: 1103–1104, 1997
Kaufman Z, Garstin WIH, Hayes R, Michell MJ, Baum M: The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 43: 389–392, 1991
van Gils CH, Otten JDM, Verbeek AL, Hendriks JH, Holland R: Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands. J Epidemiol Communit Health 52: 267–271, 1998
Litherland JC, Evans AJ, Wilson AR: The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radio 52: 276–279, 1997
Laya MB, Larson EB, Taplin SH, White E: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 88: 643–649, 1996
Thurfjell EL, Holmberg LH, Persson IR: Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 203: 339–341, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sterns, E.E., Zee, B. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?. Breast Cancer Res Treat 59, 125–132 (2000). https://doi.org/10.1023/A:1006326432340
Issue Date:
DOI: https://doi.org/10.1023/A:1006326432340